A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Netherton Syndrome

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

June 12, 2023

Primary Completion Date

January 13, 2025

Study Completion Date

July 31, 2025

Conditions
Netherton Syndrome
Interventions
DRUG

Spesolimab - solution for infusion

Solution for infusion

DRUG

Placebo matching to spesolimab - solution for infusion

Solution for infusion

DRUG

Spesolimab - solution for injection

Solution for injection

DRUG

Placebo matching to spesolimab - solution for injection

Solution for injection

Trial Locations (28)

1407

ASMC-IPSMC-skin and Veneral Diseases, Sofia

2145

Westmead Hospital, Westmead

8032

University Children Hospital Zürich, Zurich

10126

AO Città della Salute e Scienza, Torino

23502

Virginia Clinical Research, Inc., Norfolk

24105

Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel

29425

Medical University of South Carolina, Charleston

50300

Hospital Tunku Azizah, Kuala Lumpur

69120

Universitätsklinikum Heidelberg, Heidelberg

75010

HOP Saint-Louis, Paris

80337

Klinikum der Universität München AÖR, München

92688

Mission Dermatology Center, Rancho Santa Margarita

100045

Beijing Children's Hospital, Capital Medical University, Beijing

200000

Shanghai Skin Disease Hospital, Shanghai

200092

Xinhua Hospital Affiliated to Shanghai Jiaotong University, Shanghai

210000

Dermatology Hospital, Chinese Academy of Medical Sciences, Nanjing

310000

The Children's Hospital Zhejiang University School Of Medicine, Hangzhou

310003

The First Affiliated Hospital, Zhejiang University, Hangzhou

510091

Southern Medical University Dermatology Hospital, Guangzhou

6423906

Sourasky Medical Center, Tel Aviv

06519

Yale University School of Medicine, New Haven

00167

Istituto Dermopatico Dell'Immacolata - IDI - IRCCS, Roma

466-8560

Nagoya University Hospital, Aichi, Nagoya

279-0021

Juntendo University Urayasu Hospital, Chiba, Urayasu

700-8558

Okayama University Hospital, Okayama, Okayama

3015 GD

Erasmus MC - Sophia Kinderziekenhuis, Rotterdam

1169-050

ULS de São José, E.P.E. - Hospital Sto. António Capuchos, Lisbon

G51 4TF

Queen Elizabeth University Hospital, Glasgow

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT05856526 - A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Netherton Syndrome | Biotech Hunter | Biotech Hunter